Concepedia

Publication | Closed Access

Effect of interleukin-6 inhibition on coronary microvascular and endothelial function in myocardial infarction

54

Citations

19

References

2017

Year

Abstract

Tocilizumab did not affect CFR during hospitalisation or after 6 months. Tocilizumab increased VCAM-1 levels during hospitalisation, but this was not associated with reduced CFR in these patients.

References

YearCitations

Page 1